(Q54522229)

30 May 2018

title

AMPK and GCN2-ATF4 signal the repression of mitochondria in colon cancer cells. (English)

1 reference

30 May 2018

1 reference

1 reference

Inmaculada Martínez-Reyes

series ordinal

1

1 reference

30 May 2018

María Sánchez-Aragó

series ordinal

2

1 reference

30 May 2018

José M Cuezva

series ordinal

3

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 June 2012

1 reference

30 May 2018

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Biochemical Journal

1 reference

30 May 2018

volume

444

1 reference

30 May 2018

issue

2

1 reference

30 May 2018

page(s)

249-259

1 reference

30 May 2018

A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Transcriptional paradigms in mammalian mitochondrial biogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

The ATP synthase--a splendid molecular machine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Changing patterns of transcriptional and post-transcriptional control of beta-F1-ATPase gene expression during mitochondrial biogenesis in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Biogenesis and dynamics of mitochondria during the cell cycle: significance of 3'UTRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Selective inhibition of beta-F1-ATPase mRNA translation in human tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

In Saccharomyces cerevisiae, ATP2 mRNA sorting to the vicinity of mitochondria is essential for respiratory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Human G3BP1 interacts with beta-F1-ATPase mRNA and inhibits its translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Selection of cancer cells with repressed mitochondria triggers colon cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Management of cellular energy by the AMP-activated protein kinase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Antiviral effect of the mammalian translation initiation factor 2alpha kinase GCN2 against RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Regulated translation initiation controls stress-induced gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Oligomycin inhibits HIF-1alpha expression in hypoxic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Growing roles for the mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Translational control in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

RNA regulons: coordination of post-transcriptional events

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Epigenetic regulation of the binding activity of translation inhibitory proteins that bind the 3' untranslated region of beta-F1-ATPase mRNA by adenine nucleotides and the redox state

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

AMP-activated kinase regulates cytoplasmic HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Inhibition of AMP-activated protein kinase sensitizes cancer cells to cisplatin-induced apoptosis via hyper-induction of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Hypoxia-induced energy stress regulates mRNA translation and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111829

21 January 2018

Identifiers

DOI

10.1042/BJ20111829

1 reference

30 May 2018

PubMed ID

22435535

1 reference

30 May 2018